RGNX

REGENXBIO Inc.NASDAQHealthcare

$8.53-1.16%ClosedMarket Cap: $440.3M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-09	HC Wainwright & Co.	—	Buy	—
2026-03-06	Morgan Stanley	—	Overweight	—
2026-02-10	Goldman Sachs	—	Neutral	—
2026-02-10	Chardan Capital	—	Buy	—
2025-12-19	Stifel	—	Buy	—
2025-12-15	Leerink Partners	—	Outperform	—
2025-11-20	Chardan Capital	—	Buy	—
2025-11-07	RBC Capital	—	Outperform	—
2025-10-07	HC Wainwright & Co.	—	Buy	—
2025-09-08	Chardan Capital	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-2.81	$297.1M	5
Sun Dec 31	$-1.40	$489.5M	4
Mon Dec 31	$2.24	$725.1M	2
Tue Dec 31	$6.21	$977.8M	2